Developmental regulation and neuroprotective effects of striatal tonic GABAA currents

Neuroscience

Volumn 167, Issue 3, 2010, Pages 644-655

  Santhakumar, V ^a   Jones, R T ^a,b   Mody, I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell swelling; Delta subunit; Excitotoxicity; Huntington's disease; Medium spiny neuron

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL SWELLING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXCITOTOXICITY; IN VITRO STUDY; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX; SUBSTANTIA NIGRA; SYNAPTIC INHIBITION;

ANIMALS; CELL SIZE; CORPUS STRIATUM; CYTOPROTECTION; EXCITATORY AMINO ACID AGONISTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCIMOL; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PROTEIN SUBUNITS; RECEPTORS, GABA-A;

EID: 77951297410     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.02.048     Document Type: Article

References (58)

1. Ade K.K., Janssen M.J., Ortinski P.I., Vicini S. Differential tonic GABA conductances in striatal medium spiny neurons. J Neurosci 2008, 28:1185-1197.
2. Albin R.L., Reiner A., Anderson K.D., Dure L.S., Handelin B., Balfour R., Whetsell W.O., Penney J.B., Young A.B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 1992, 31:425-430.
3. Balleine B.W., Delgado M.R., Hikosaka O. The role of the dorsal striatum in reward and decision-making. J Neurosci 2007, 27:8161-8165.
4. Beister A., Kraus P., Kuhn W., Dose M., Weindl A., Gerlach M. The N-methyl-d-aspartate antagonist memantine retards progression of Huntington's disease. J Neural Transm Suppl 2004, 68:117-122.
5. Bracci E., Panzeri S. Excitatory GABAergic effects in striatal projection neurons. J Neurophysiol 2006, 95:1285-1290.
6. Brown N., Kerby J., Bonnert T.P., Whiting P.J., Wafford K.A. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br J Pharmacol 2002, 136:965-974.
7. Cepeda C., Andre V.M., Yamazaki I., Wu N., Kleiman-Weiner M., Levine M.S. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Eur J Neurosci 2008, 27:671-682.
8. Colwell C.S., Levine M.S. Glutamate receptor-induced toxicity in neostriatal cells. Brain Res 1996, 724:205-212.
9. Day M., Wokosin D., Plotkin J.L., Tian X., Surmeier D.J. Differential excitability and modulation of striatal medium spiny neuron dendrites. J Neurosci 2008, 28:11603-11614.
10. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat 2004, 27:143-164.
11. Estrada Sanchez A.M., Mejia-Toiber J., Massieu L. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch Med Res 2008, 39:265-276.
12. Farrant M., Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005, 6:215-229.
13. Fujiyama F., Fritschy J.M., Stephenson F.A., Bolam J.P. Synaptic localization of GABA(A) receptor subunits in the striatum of the rat. J Comp Neurol 2000, 416:158-172.
14. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
15. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 1988, 460:161-167.
16. Gertler T.S., Chan C.S., Surmeier D.J. Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci 2008, 28:10814-10824.
17. Glykys J., Mody I. Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. J Neurophysiol 2006, 95:2796-2807.
18. Glykys J., Mody I. The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. J Physiol 2007, 582:1163-1178.
19. Gong S., Zheng C., Doughty M.L., Losos K., Didkovsky N., Schambra U.B., Nowak N.J., Joyner A., Leblanc G., Hatten M.E., Heintz N. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 2003, 425:917-925.
20. Graveland G.A., Williams R.S., DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985, 227:770-773.
21. Heintz N. Gene expression nervous system atlas (GENSAT). Nat Neurosci 2004, 7:483.
22. Hevers W., Luddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 1998, 18:35-86.
23. Huang Q., Zhou D., Sapp E., Aizawa H., Ge P., Bird E.D., Vonsattel J.P., DiFiglia M. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Neuroscience 1995, 65:397-407.
24. Janssen M.J., Ade K.K., Fu Z., Vicini S. Dopamine modulation of GABA tonic conductance in striatal output neurons. J Neurosci 2009, 29:5116-5126.
25. Kawaguchi Y. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 1993, 13:4908-4923.
26. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995, 18:527-535.
27. Kawaguchi Y., Wilson C.J., Emson P.C. Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 1989, 62:1052-1068.
28. Kirmse K., Dvorzhak A., Kirischuk S., Grantyn R. GABA transporter 1 tunes GABAergic synaptic transmission at output neurons of the mouse neostriatum. J Physiol 2008, 586:5665-5678.
29. Koos T., Tepper J.M., Wilson C.J. Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J Neurosci 2004, 24:7916-7922.
30. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
31. Kremer B., Clark C.M., Almqvist E.W., Raymond L.A., Graf P., Jacova C., Mezei M., Hardy M.A., Snow B., Martin W., Hayden M.R. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology 1999, 53:1000-1011.
32. Laurie D.J., Wisden W., Seeburg P.H. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain: part III. Embryonic and postnatal development. J Neurosci 1992, 12:4151-4172.
33. Le M.C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci U S A 1991, 88:4205-4209.
34. Lucetti C., Gambaccini G., Bernardini S., Dell'Agnello G., Petrozzi L., Rossi G., Bonuccelli U. Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci 2002, 23(Suppl 2):S83-S84.
35. McGeer E.G., McGeer P.L. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 1976, 263:517-519.
36. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., Lagenaur C., Tretter V., Sieghart W., Anagnostaras S.G., Sage J.R., Fanselow M.S., Guidotti A., Spigelman I., Li Z., DeLorey T.M., Olsen R.W., Homanics G.E. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A 1999, 96:12905-12910.
37. Mody I., Pearce R.A. Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 2004, 27:569-575.
38. Monette R., Small D.L., Mealing G., Morley P. A fluorescence confocal assay to assess neuronal viability in brain slices. Brain Res Brain Res Protoc 1998, 2:99-108.
39. Murman D.L., Giordani B., Mellow A.M., Johanns J.R., Little R.J., Hariharan M., Foster N.L. Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease. Neurology 1997, 49:153-161.
40. Nakano K., Kayahara T., Tsutsumi T., Ushiro H. Neural circuits and functional organization of the striatum. J Neurol 2000, 247(Suppl 5):V1-V15.
41. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
42. Ratzliff A.H., Howard A.L., Santhakumar V., Osapay I., Soltesz I. Rapid deletion of mossy cells does not result in a hyperexcitable dentate gyrus: implications for epileptogenesis. J Neurosci 2004, 24:2259-2269.
43. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988, 85:5733-5737.
44. Santhakumar V, Mody I (2008) Developmental regulation and neuroprotective effects of striatal tonic inhibition. In: 2008 Neuroscience Meeting Planner, Society for Neuroscience, Washington DC, USA, 424.6/C7, 2008.
45. Schultz W. Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 2006, 57:87-115.
46. Schwarcz R., Coyle J.T. Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat. Life Sci 1977, 20:431-436.
47. Schwarzer C., Berresheim U., Pirker S., Wieselthaler A., Fuchs K., Sieghart W., Sperk G. Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol 2001, 433:526-549.
48. Shivers B.D., Killisch I., Sprengel R., Sontheimer H., Kohler M., Schofield P.R., Seeburg P.H. Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron 1989, 3:327-337.
49. Surmeier D.J., Ding J., Day M., Wang Z., Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007, 30:228-235.
50. Surmeier D.J., Kitai S.T. Dopaminergic regulation of striatal efferent pathways. Curr Opin Neurobiol 1994, 4:915-919.
51. Tanaka Y., Tanaka Y., Furuta T., Yanagawa Y., Kaneko T. The effects of cutting solutions on the viability of GABAergic interneurons in cerebral cortical slices of adult mice. J Neurosci Methods 2008, 171:118-125.
52. Taverna S., Canciani B., Pennartz C.M. Membrane properties and synaptic connectivity of fast-spiking interneurons in rat ventral striatum. Brain Res 2007, 1152:49-56.
53. Taverna S., Ilijic E., Surmeier D.J. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 2008, 28:5504-5512.
54. Tepper J.M., Koos T., Wilson C.J. GABAergic microcircuits in the neostriatum. Trends Neurosci 2004, 27:662-669.
55. Valjent E., Bertran-Gonzalez J., Herve D., Fisone G., Girault J.A. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends Neurosci 2009, 32:538-547.
56. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985, 44:559-577.
57. Wilson C.J. GABAergic inhibition in the neostriatum. Prog Brain Res 2007, 160:91-110.
58. Wilson C.J., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. J Comp Neurol 1980, 194:599-615.